Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.70539438 |
2 | NIK/NF-kappaB signaling (GO:0038061) | 7.60645913 |
3 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 7.28740571 |
4 | positive regulation of antigen processing and presentation (GO:0002579) | 5.95892150 |
5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.48153725 |
6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.48153725 |
7 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.18025808 |
8 | regulation of antigen processing and presentation (GO:0002577) | 5.13792842 |
9 | regulation of activation of Janus kinase activity (GO:0010533) | 5.11652998 |
10 | positive regulation of interleukin-12 production (GO:0032735) | 5.06820618 |
11 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.95048535 |
12 | myeloid dendritic cell differentiation (GO:0043011) | 4.83325891 |
13 | regulation of RIG-I signaling pathway (GO:0039535) | 4.68601730 |
14 | positive regulation of type 2 immune response (GO:0002830) | 4.65264013 |
15 | positive regulation of T-helper cell differentiation (GO:0045624) | 4.64733947 |
16 | positive regulation of heat generation (GO:0031652) | 4.61152428 |
17 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.57184453 |
18 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.52502044 |
19 | natural killer cell mediated immunity (GO:0002228) | 4.52502044 |
20 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.47854056 |
21 | negative thymic T cell selection (GO:0045060) | 4.44810321 |
22 | negative regulation of interleukin-12 production (GO:0032695) | 4.42963944 |
23 | regulation of fever generation (GO:0031620) | 4.42929373 |
24 | immunoglobulin mediated immune response (GO:0016064) | 4.38521292 |
25 | type I interferon signaling pathway (GO:0060337) | 4.33191078 |
26 | cellular response to type I interferon (GO:0071357) | 4.33191078 |
27 | myeloid dendritic cell activation (GO:0001773) | 4.30086708 |
28 | response to type I interferon (GO:0034340) | 4.29384423 |
29 | neutrophil activation involved in immune response (GO:0002283) | 4.29221504 |
30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.27029618 |
31 | cellular response to zinc ion (GO:0071294) | 4.26599459 |
32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.24877911 |
33 | negative regulation of cell killing (GO:0031342) | 4.24877911 |
34 | positive regulation of interferon-alpha production (GO:0032727) | 4.24589158 |
35 | regulation of chronic inflammatory response (GO:0002676) | 4.24024904 |
36 | T-helper 1 type immune response (GO:0042088) | 4.23476520 |
37 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.22524658 |
38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.15190737 |
39 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.13995149 |
40 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.11613059 |
41 | neutrophil activation (GO:0042119) | 4.10777782 |
42 | negative T cell selection (GO:0043383) | 4.07420004 |
43 | dendritic cell differentiation (GO:0097028) | 4.00742359 |
44 | regulation of interferon-alpha production (GO:0032647) | 3.98723201 |
45 | granulocyte activation (GO:0036230) | 3.97360937 |
46 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.95742426 |
47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.93626860 |
48 | regulation of interleukin-12 production (GO:0032655) | 3.92469373 |
49 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.89994208 |
50 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.87369953 |
51 | regulation of T-helper cell differentiation (GO:0045622) | 3.84731410 |
52 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.74928887 |
53 | positive regulation of interleukin-2 production (GO:0032743) | 3.69771665 |
54 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.69401362 |
55 | regulation of hypersensitivity (GO:0002883) | 3.68130549 |
56 | B cell mediated immunity (GO:0019724) | 3.67781932 |
57 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.66494741 |
58 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.66381132 |
59 | response to muramyl dipeptide (GO:0032495) | 3.65511113 |
60 | regulation of memory T cell differentiation (GO:0043380) | 3.65147017 |
61 | defense response to protozoan (GO:0042832) | 3.63110291 |
62 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.59749555 |
63 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.59269401 |
64 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.53313811 |
65 | T cell migration (GO:0072678) | 3.52023649 |
66 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.49934589 |
67 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.48571243 |
68 | cellular response to exogenous dsRNA (GO:0071360) | 3.48504395 |
69 | T-helper cell differentiation (GO:0042093) | 3.48122789 |
70 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.48122789 |
71 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.48023074 |
72 | positive regulation of humoral immune response (GO:0002922) | 3.46248734 |
73 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.44084030 |
74 | growth hormone receptor signaling pathway (GO:0060396) | 3.43651143 |
75 | positive regulation of prostaglandin secretion (GO:0032308) | 3.42903223 |
76 | regulation of heat generation (GO:0031650) | 3.42896973 |
77 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.37231089 |
78 | regulation of natural killer cell differentiation (GO:0032823) | 3.36951662 |
79 | leukocyte mediated cytotoxicity (GO:0001909) | 3.36563753 |
80 | positive regulation of neutrophil migration (GO:1902624) | 3.35054867 |
81 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.35054867 |
82 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.34788332 |
83 | cellular response to interferon-beta (GO:0035458) | 3.34108899 |
84 | dendritic cell chemotaxis (GO:0002407) | 3.30700621 |
85 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.29629993 |
86 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.28642890 |
87 | positive regulation of B cell differentiation (GO:0045579) | 3.27076569 |
88 | cellular response to interferon-gamma (GO:0071346) | 3.26987074 |
89 | positive regulation of interleukin-17 production (GO:0032740) | 3.26528435 |
90 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.25142586 |
91 | regulation of prostaglandin secretion (GO:0032306) | 3.24310753 |
92 | macrophage activation involved in immune response (GO:0002281) | 3.23664110 |
93 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.22825292 |
94 | monocyte chemotaxis (GO:0002548) | 3.20715317 |
95 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.20129455 |
96 | response to peptidoglycan (GO:0032494) | 3.19115133 |
97 | positive regulation of natural killer cell activation (GO:0032816) | 3.18617615 |
98 | positive regulation of osteoclast differentiation (GO:0045672) | 3.17924505 |
99 | natural killer cell differentiation (GO:0001779) | 3.17810471 |
100 | regulation of vitamin metabolic process (GO:0030656) | 3.17647145 |
101 | response to interferon-gamma (GO:0034341) | 3.17116019 |
102 | regulation of immunoglobulin secretion (GO:0051023) | 3.16358449 |
103 | lymphocyte mediated immunity (GO:0002449) | 3.16145132 |
104 | regulation of T-helper 1 type immune response (GO:0002825) | 3.15351205 |
105 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.14973645 |
106 | regulation of mononuclear cell migration (GO:0071675) | 3.13227318 |
107 | bone resorption (GO:0045453) | 3.13055739 |
108 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.13037182 |
109 | negative regulation of T cell mediated immunity (GO:0002710) | 3.11230788 |
110 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.10408228 |
111 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.10192721 |
112 | germinal center formation (GO:0002467) | 3.09700801 |
113 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.08955779 |
114 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.07773011 |
115 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.07253933 |
116 | positive regulation of interleukin-10 production (GO:0032733) | 3.05404406 |
117 | modulation by symbiont of host immune response (GO:0052553) | 3.05329077 |
118 | positive regulation by symbiont of host defense response (GO:0052509) | 3.05329077 |
119 | modulation by symbiont of host defense response (GO:0052031) | 3.05329077 |
120 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.05329077 |
121 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.05329077 |
122 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.05329077 |
123 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.04537992 |
124 | positive regulation of interferon-gamma production (GO:0032729) | 3.03887376 |
125 | regulation of B cell differentiation (GO:0045577) | 3.03245289 |
126 | negative regulation of viral genome replication (GO:0045071) | 3.02378400 |
127 | positive regulation of macrophage cytokine production (GO:0060907) | 3.02002449 |
128 | cytokine secretion (GO:0050663) | 3.01032847 |
129 | thymic T cell selection (GO:0045061) | 3.00859316 |
130 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.00744057 |
131 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.00744057 |
132 | T cell differentiation involved in immune response (GO:0002292) | 3.00744057 |
133 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.99763662 |
134 | positive regulation of defense response to virus by host (GO:0002230) | 2.99176070 |
135 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.98753975 |
136 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.98723182 |
137 | positive regulation of activated T cell proliferation (GO:0042104) | 2.98225700 |
138 | response to protozoan (GO:0001562) | 2.97976685 |
139 | positive regulation of T cell cytokine production (GO:0002726) | 2.97570287 |
140 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.94850048 |
141 | regulation of defense response to virus by host (GO:0050691) | 2.94405845 |
142 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.94336749 |
143 | tolerance induction (GO:0002507) | 2.91064436 |
144 | regulation of podosome assembly (GO:0071801) | 2.88439493 |
145 | positive regulation of B cell mediated immunity (GO:0002714) | 2.85027811 |
146 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.85027811 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.53978900 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.51936534 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.76227121 |
4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.09836477 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.97339882 |
6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.06442568 |
7 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.72216173 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.61928405 |
9 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.32519515 |
10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.24114030 |
11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.07642853 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.01995535 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01364457 |
14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.93164179 |
15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.91699318 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.65155454 |
17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.55278149 |
18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.38460015 |
19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.36492952 |
20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.29586139 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.29371523 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.06065781 |
23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.03580471 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 2.02485043 |
25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85654134 |
26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.85309894 |
27 | MYB_26560356_Chip-Seq_TH1_Human | 1.82417066 |
28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.80926294 |
29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79938479 |
30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73556072 |
31 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.71699669 |
32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.67721835 |
33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63470244 |
34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59608400 |
35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57158262 |
36 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51688083 |
37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49215236 |
38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.47353323 |
39 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.44505465 |
40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41815501 |
41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35698622 |
42 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35493762 |
43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34346807 |
44 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.33498514 |
45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33159736 |
46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32095882 |
47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29297378 |
48 | MYC_22102868_ChIP-Seq_BL_Human | 1.28985350 |
49 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28600407 |
50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22942534 |
51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21680302 |
52 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21409540 |
53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19337799 |
54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15645152 |
55 | * MAF_26560356_Chip-Seq_TH2_Human | 1.13321875 |
56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12680518 |
57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12178894 |
58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.11622596 |
59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11073893 |
60 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.10817999 |
61 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09733302 |
62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09211731 |
63 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08118079 |
64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07844905 |
65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06763494 |
66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.06208614 |
67 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06037049 |
68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05768415 |
69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05141206 |
70 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03682929 |
71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01981372 |
72 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01755391 |
73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00248230 |
74 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99224676 |
75 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98844875 |
76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95768992 |
77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94981501 |
78 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93979792 |
79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89882440 |
80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89303234 |
81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88404204 |
82 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87922695 |
83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87302624 |
84 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.87141636 |
85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.87027425 |
86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86113781 |
87 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85746717 |
88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85538256 |
89 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85325685 |
90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85236204 |
91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85076350 |
92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79891954 |
93 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.78833249 |
94 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.78181999 |
95 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.76992496 |
96 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74386608 |
97 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73896246 |
98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72607345 |
99 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.69917829 |
100 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.66814536 |
101 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.66814536 |
102 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65614515 |
103 | P300_27268052_Chip-Seq_Bcells_Human | 0.63979737 |
104 | GATA3_26560356_Chip-Seq_TH1_Human | 0.63645155 |
105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.60356675 |
106 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.60278005 |
107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.60121973 |
108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.59955986 |
109 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.59731219 |
110 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.58769636 |
111 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.58648332 |
112 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.57281456 |
113 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.56406350 |
114 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.55911669 |
115 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55532187 |
116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.55518592 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 5.85087877 |
2 | MP0000685_abnormal_immune_system | 4.75125752 |
3 | MP0002254_reproductive_system_inflammat | 4.69351148 |
4 | MP0001348_abnormal_lacrimal_gland | 3.97794283 |
5 | MP0004510_myositis | 3.93540866 |
6 | MP0005387_immune_system_phenotype | 3.74808124 |
7 | MP0001790_abnormal_immune_system | 3.74808124 |
8 | MP0002138_abnormal_hepatobiliary_system | 3.53265314 |
9 | MP0002148_abnormal_hypersensitivity_rea | 3.53078217 |
10 | MP0005671_abnormal_response_to | 3.43288396 |
11 | MP0009785_altered_susceptibility_to | 3.26345215 |
12 | MP0001800_abnormal_humoral_immune | 3.05206608 |
13 | MP0005310_abnormal_salivary_gland | 3.02903871 |
14 | MP0005000_abnormal_immune_tolerance | 2.93310505 |
15 | MP0001346_abnormal_lacrimal_gland | 2.92302706 |
16 | MP0002452_abnormal_antigen_presenting | 2.69420718 |
17 | MP0002163_abnormal_gland_morphology | 2.59318943 |
18 | MP0002723_abnormal_immune_serum | 2.55094151 |
19 | MP0005025_abnormal_response_to | 2.54619789 |
20 | MP0003436_decreased_susceptibility_to | 2.49189283 |
21 | MP0002419_abnormal_innate_immunity | 2.28121243 |
22 | MP0001819_abnormal_immune_cell | 2.28086728 |
23 | MP0002420_abnormal_adaptive_immunity | 2.24705081 |
24 | MP0002166_altered_tumor_susceptibility | 2.18658822 |
25 | MP0006082_CNS_inflammation | 2.13785932 |
26 | MP0003303_peritoneal_inflammation | 2.07244782 |
27 | MP0002006_tumorigenesis | 2.05503967 |
28 | MP0001853_heart_inflammation | 2.03667878 |
29 | MP0002139_abnormal_hepatobiliary_system | 2.03558145 |
30 | MP0001873_stomach_inflammation | 1.97774469 |
31 | MP0002876_abnormal_thyroid_physiology | 1.92479084 |
32 | MP0002405_respiratory_system_inflammati | 1.82556980 |
33 | MP0000716_abnormal_immune_system | 1.82545248 |
34 | MP0002398_abnormal_bone_marrow | 1.78939232 |
35 | MP0003191_abnormal_cellular_cholesterol | 1.64006631 |
36 | MP0001845_abnormal_inflammatory_respons | 1.61091212 |
37 | MP0002277_abnormal_respiratory_mucosa | 1.57526609 |
38 | MP0004947_skin_inflammation | 1.54481117 |
39 | MP0003763_abnormal_thymus_physiology | 1.53432658 |
40 | MP0008057_abnormal_DNA_replication | 1.50128500 |
41 | MP0010155_abnormal_intestine_physiology | 1.46181701 |
42 | MP0002429_abnormal_blood_cell | 1.40474825 |
43 | MP0003195_calcinosis | 1.35084736 |
44 | MP0005167_abnormal_blood-brain_barrier | 1.31620844 |
45 | MP0003448_altered_tumor_morphology | 1.31214854 |
46 | MP0002877_abnormal_melanocyte_morpholog | 1.30864319 |
47 | MP0009333_abnormal_splenocyte_physiolog | 1.27220672 |
48 | MP0002722_abnormal_immune_system | 1.26223253 |
49 | MP0008469_abnormal_protein_level | 1.25702087 |
50 | MP0009764_decreased_sensitivity_to | 1.24818593 |
51 | MP0005451_abnormal_body_composition | 1.23250705 |
52 | MP0000689_abnormal_spleen_morphology | 1.22479824 |
53 | MP0005379_endocrine/exocrine_gland_phen | 1.20576185 |
54 | MP0003806_abnormal_nucleotide_metabolis | 1.15051022 |
55 | MP0000465_gastrointestinal_hemorrhage | 1.13220972 |
56 | MP0003724_increased_susceptibility_to | 1.12112061 |
57 | MP0001533_abnormal_skeleton_physiology | 1.06001782 |
58 | MP0000569_abnormal_digit_pigmentation | 1.05986838 |
59 | MP0003091_abnormal_cell_migration | 1.04685493 |
60 | MP0005076_abnormal_cell_differentiation | 1.04550943 |
61 | MP0005464_abnormal_platelet_physiology | 1.04499628 |
62 | MP0002009_preneoplasia | 1.04133475 |
63 | MP0005166_decreased_susceptibility_to | 1.03817268 |
64 | MP0010352_gastrointestinal_tract_polyps | 0.96635353 |
65 | MP0000858_altered_metastatic_potential | 0.95646549 |
66 | MP0005397_hematopoietic_system_phenotyp | 0.92970623 |
67 | MP0001545_abnormal_hematopoietic_system | 0.92970623 |
68 | MP0003183_abnormal_peptide_metabolism | 0.90339125 |
69 | MP0000703_abnormal_thymus_morphology | 0.89381464 |
70 | MP0003453_abnormal_keratinocyte_physiol | 0.89344863 |
71 | MP0000920_abnormal_myelination | 0.87860986 |
72 | MP0003656_abnormal_erythrocyte_physiolo | 0.87172367 |
73 | MP0008004_abnormal_stomach_pH | 0.86354090 |
74 | MP0003828_pulmonary_edema | 0.81637826 |
75 | MP0003690_abnormal_glial_cell | 0.80062059 |
76 | MP0003300_gastrointestinal_ulcer | 0.78673322 |
77 | MP0002332_abnormal_exercise_endurance | 0.78269902 |
78 | MP0009278_abnormal_bone_marrow | 0.74738165 |
79 | MP0003045_fibrosis | 0.72460846 |
80 | MP0005165_increased_susceptibility_to | 0.71790764 |
81 | MP0003795_abnormal_bone_structure | 0.71472317 |
82 | MP0001501_abnormal_sleep_pattern | 0.67675500 |
83 | MP0002693_abnormal_pancreas_physiology | 0.67244466 |
84 | MP0008874_decreased_physiological_sensi | 0.67203286 |
85 | MP0001881_abnormal_mammary_gland | 0.65563632 |
86 | MP0003172_abnormal_lysosome_physiology | 0.65203295 |
87 | MP0000613_abnormal_salivary_gland | 0.65108435 |
88 | MP0005647_abnormal_sex_gland | 0.64324991 |
89 | MP0010307_abnormal_tumor_latency | 0.63777135 |
90 | MP0002998_abnormal_bone_remodeling | 0.63763823 |
91 | MP0004782_abnormal_surfactant_physiolog | 0.62085366 |
92 | MP0009763_increased_sensitivity_to | 0.61264152 |
93 | MP0002136_abnormal_kidney_physiology | 0.60719220 |
94 | MP0000609_abnormal_liver_physiology | 0.60649846 |
95 | MP0003075_altered_response_to | 0.57308615 |
96 | MP0000604_amyloidosis | 0.57254798 |
97 | MP0000371_diluted_coat_color | 0.56990704 |
98 | MP0001542_abnormal_bone_strength | 0.56508171 |
99 | MP0006054_spinal_hemorrhage | 0.56380180 |
100 | MP0004808_abnormal_hematopoietic_stem | 0.55594498 |
101 | MP0003866_abnormal_defecation | 0.54712904 |
102 | MP0005164_abnormal_response_to | 0.53763265 |
103 | MP0000627_abnormal_mammary_gland | 0.53718038 |
104 | MP0002933_joint_inflammation | 0.53699278 |
105 | MP0002396_abnormal_hematopoietic_system | 0.53597979 |
106 | MP0001727_abnormal_embryo_implantation | 0.51611328 |
107 | MP0005645_abnormal_hypothalamus_physiol | 0.51040004 |
108 | MP0000470_abnormal_stomach_morphology | 0.50854611 |
109 | MP0000767_abnormal_smooth_muscle | 0.50331456 |
110 | MP0005535_abnormal_body_temperature | 0.49554889 |
111 | MP0003566_abnormal_cell_adhesion | 0.47513043 |
112 | MP0009840_abnormal_foam_cell | 0.47205926 |
113 | MP0005058_abnormal_lysosome_morphology | 0.46620174 |
114 | MP0000249_abnormal_blood_vessel | 0.46509822 |
115 | MP0005410_abnormal_fertilization | 0.45203958 |
116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.44754704 |
117 | MP0005319_abnormal_enzyme/_coenzyme | 0.44137053 |
118 | MP0000343_altered_response_to | 0.43751942 |
119 | MP0002019_abnormal_tumor_incidence | 0.41266078 |
120 | MP0001851_eye_inflammation | 0.40679846 |
121 | MP0001663_abnormal_digestive_system | 0.40386667 |
122 | MP0005174_abnormal_tail_pigmentation | 0.39986966 |
123 | MP0009765_abnormal_xenobiotic_induced | 0.39037107 |
124 | MP0009115_abnormal_fat_cell | 0.38150298 |
125 | MP0003646_muscle_fatigue | 0.37887082 |
126 | MP0005390_skeleton_phenotype | 0.36134991 |
127 | MP0002928_abnormal_bile_duct | 0.35853714 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.16048465 |
2 | Abnormality of glycolipid metabolism (HP:0010969) | 5.86714618 |
3 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.86714618 |
4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.86714618 |
5 | Recurrent bacterial skin infections (HP:0005406) | 5.62007574 |
6 | Increased IgM level (HP:0003496) | 5.41724015 |
7 | Recurrent abscess formation (HP:0002722) | 5.35496823 |
8 | Recurrent fungal infections (HP:0002841) | 5.13155587 |
9 | Recurrent cutaneous fungal infections (HP:0011370) | 5.04959564 |
10 | Chronic mucocutaneous candidiasis (HP:0002728) | 5.04959564 |
11 | Chronic otitis media (HP:0000389) | 4.92825336 |
12 | Agammaglobulinemia (HP:0004432) | 4.90314433 |
13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.71990043 |
14 | Vacuolated lymphocytes (HP:0001922) | 4.59216573 |
15 | Autoimmune thrombocytopenia (HP:0001973) | 4.56324305 |
16 | Vasculitis (HP:0002633) | 4.53912430 |
17 | Recurrent skin infections (HP:0001581) | 4.52513557 |
18 | Dysostosis multiplex (HP:0000943) | 4.51499463 |
19 | Mediastinal lymphadenopathy (HP:0100721) | 4.49636093 |
20 | Recurrent viral infections (HP:0004429) | 4.45650962 |
21 | Optic neuritis (HP:0100653) | 4.24201472 |
22 | Retrobulbar optic neuritis (HP:0100654) | 4.24201472 |
23 | Myositis (HP:0100614) | 4.23850135 |
24 | Nasal polyposis (HP:0100582) | 4.22856128 |
25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.19935038 |
26 | Recurrent bronchitis (HP:0002837) | 4.16798512 |
27 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.10664020 |
28 | Loss of speech (HP:0002371) | 4.04092686 |
29 | Hypergammaglobulinemia (HP:0010702) | 3.94102404 |
30 | Gastrointestinal infarctions (HP:0005244) | 3.93046801 |
31 | Increased cerebral lipofuscin (HP:0011813) | 3.91682921 |
32 | Colitis (HP:0002583) | 3.87660045 |
33 | Gastrointestinal stroma tumor (HP:0100723) | 3.84887154 |
34 | Systemic lupus erythematosus (HP:0002725) | 3.82990619 |
35 | Orchitis (HP:0100796) | 3.82106574 |
36 | Abnormality of macrophages (HP:0004311) | 3.80141093 |
37 | Cellulitis (HP:0100658) | 3.70666645 |
38 | Chronic sinusitis (HP:0011109) | 3.65592385 |
39 | Keratoconjunctivitis (HP:0001096) | 3.64345376 |
40 | Increased IgE level (HP:0003212) | 3.56191187 |
41 | Interstitial pulmonary disease (HP:0006530) | 3.51493779 |
42 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.48634461 |
43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.48634461 |
44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.48634461 |
45 | Abnormality of the nasal mucosa (HP:0000433) | 3.45859526 |
46 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.36962595 |
47 | Mucopolysacchariduria (HP:0008155) | 3.36962595 |
48 | Pulmonary infiltrates (HP:0002113) | 3.35841071 |
49 | Inflammation of the large intestine (HP:0002037) | 3.34715677 |
50 | Meningitis (HP:0001287) | 3.32897784 |
51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.32261624 |
52 | Gingivitis (HP:0000230) | 3.25904489 |
53 | Thrombocytosis (HP:0001894) | 3.24384497 |
54 | Recurrent pneumonia (HP:0006532) | 3.20325007 |
55 | Gastrointestinal inflammation (HP:0004386) | 3.17176783 |
56 | Recurrent lower respiratory tract infections (HP:0002783) | 3.16186974 |
57 | Emphysema (HP:0002097) | 3.14337275 |
58 | Panhypogammaglobulinemia (HP:0003139) | 3.11353207 |
59 | Tetraparesis (HP:0002273) | 3.09385694 |
60 | Disinhibition (HP:0000734) | 3.02618025 |
61 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.98815822 |
62 | Arterial thrombosis (HP:0004420) | 2.98279491 |
63 | Eosinophilia (HP:0001880) | 2.96932122 |
64 | Combined immunodeficiency (HP:0005387) | 2.94401808 |
65 | Basal ganglia calcification (HP:0002135) | 2.93578020 |
66 | Recurrent sinusitis (HP:0011108) | 2.91965365 |
67 | IgA deficiency (HP:0002720) | 2.86069574 |
68 | Mutism (HP:0002300) | 2.84181469 |
69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.80858226 |
70 | Obstructive lung disease (HP:0006536) | 2.80858226 |
71 | Abnormality of T cell physiology (HP:0011840) | 2.80462640 |
72 | Abnormality of T cell number (HP:0011839) | 2.75506012 |
73 | Lymphopenia (HP:0001888) | 2.72383445 |
74 | Periodontitis (HP:0000704) | 2.67246689 |
75 | Autoimmune hemolytic anemia (HP:0001890) | 2.65651879 |
76 | Severe combined immunodeficiency (HP:0004430) | 2.64185317 |
77 | Granulocytopenia (HP:0001913) | 2.63949210 |
78 | Keratoconjunctivitis sicca (HP:0001097) | 2.58298975 |
79 | Urticaria (HP:0001025) | 2.57012626 |
80 | Osteomyelitis (HP:0002754) | 2.56012852 |
81 | Encephalitis (HP:0002383) | 2.55185287 |
82 | Gangrene (HP:0100758) | 2.54993829 |
83 | Leukocytosis (HP:0001974) | 2.53264314 |
84 | Porencephaly (HP:0002132) | 2.52509455 |
85 | Fatigue (HP:0012378) | 2.51908887 |
86 | Abnormality of proline metabolism (HP:0010907) | 2.50645981 |
87 | Hydroxyprolinuria (HP:0003080) | 2.50645981 |
88 | Bronchitis (HP:0012387) | 2.50138197 |
89 | Asymmetric septal hypertrophy (HP:0001670) | 2.49007950 |
90 | Abnormality of T cells (HP:0002843) | 2.46201929 |
91 | IgG deficiency (HP:0004315) | 2.45520962 |
92 | Hemoptysis (HP:0002105) | 2.42589055 |
93 | Hypochromic anemia (HP:0001931) | 2.41630765 |
94 | Hepatosplenomegaly (HP:0001433) | 2.41267915 |
95 | Gingival bleeding (HP:0000225) | 2.40046576 |
96 | Pustule (HP:0200039) | 2.39113041 |
97 | Chronic diarrhea (HP:0002028) | 2.35259796 |
98 | Polyneuropathy (HP:0001271) | 2.34447128 |
99 | Chest pain (HP:0100749) | 2.34379782 |
100 | Glomerulonephritis (HP:0000099) | 2.32948668 |
101 | Myocardial infarction (HP:0001658) | 2.32509482 |
102 | Abnormality of eosinophils (HP:0001879) | 2.31802218 |
103 | Abnormality of the fingertips (HP:0001211) | 2.29176168 |
104 | IgM deficiency (HP:0002850) | 2.28504576 |
105 | Progressive neurologic deterioration (HP:0002344) | 2.28322095 |
106 | Persistence of primary teeth (HP:0006335) | 2.26499894 |
107 | Arthralgia (HP:0002829) | 2.26496323 |
108 | Skin ulcer (HP:0200042) | 2.19588934 |
109 | Increased serum ferritin (HP:0003281) | 2.19266224 |
110 | Abnormality of B cell number (HP:0010975) | 2.18474022 |
111 | Amaurosis fugax (HP:0100576) | 2.18315823 |
112 | Papilloma (HP:0012740) | 2.17535380 |
113 | Verrucae (HP:0200043) | 2.17535380 |
114 | Abnormality of the pleura (HP:0002103) | 2.16963810 |
115 | B lymphocytopenia (HP:0010976) | 2.15075898 |
116 | Purpura (HP:0000979) | 2.14884673 |
117 | Pulmonary fibrosis (HP:0002206) | 2.14146416 |
118 | Sepsis (HP:0100806) | 2.13474390 |
119 | Hypertensive crisis (HP:0100735) | 2.12212258 |
120 | Acrocyanosis (HP:0001063) | 2.11944453 |
121 | Metaphyseal irregularity (HP:0003025) | 2.11730135 |
122 | Increased density of long bones (HP:0006392) | 2.10797811 |
123 | Viral hepatitis (HP:0006562) | 2.10479181 |
124 | Hematochezia (HP:0002573) | 2.10333947 |
125 | Petechiae (HP:0000967) | 2.09837671 |
126 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.06673572 |
127 | Thyroiditis (HP:0100646) | 2.04005917 |
128 | Neurofibrillary tangles (HP:0002185) | 2.03161317 |
129 | Nuclear cataract (HP:0100018) | 2.03152096 |
130 | Apathy (HP:0000741) | 2.02808281 |
131 | Anorexia (HP:0002039) | 2.01410783 |
132 | Restrictive lung disease (HP:0002091) | 2.01057342 |
133 | Stomatitis (HP:0010280) | 2.00983360 |
134 | Abnormality of the prostate (HP:0008775) | 1.98094122 |
135 | Premature loss of primary teeth (HP:0006323) | 1.97427993 |
136 | Neutropenia (HP:0001875) | 1.97418815 |
137 | Joint swelling (HP:0001386) | 1.95896859 |
138 | Osteolytic defects of the hand bones (HP:0009699) | 1.94113952 |
139 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.94113952 |
140 | Leukopenia (HP:0001882) | 1.92872318 |
141 | Keratitis (HP:0000491) | 1.89032960 |
142 | T lymphocytopenia (HP:0005403) | 1.88971325 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 6.60787315 |
2 | TBK1 | 3.76941831 |
3 | TYK2 | 3.68691523 |
4 | MAP3K13 | 3.65448145 |
5 | JAK3 | 3.62815002 |
6 | IKBKB | 3.47482995 |
7 | RIPK4 | 3.32091961 |
8 | MAP4K1 | 2.96130585 |
9 | NME2 | 2.85739210 |
10 | IRAK4 | 2.85343715 |
11 | IKBKE | 2.80875773 |
12 | CHUK | 2.75896094 |
13 | GRK7 | 2.61015468 |
14 | JAK1 | 2.45083265 |
15 | BLK | 2.37626104 |
16 | TESK2 | 2.33739208 |
17 | EPHB1 | 2.28520141 |
18 | EPHA3 | 2.23076479 |
19 | DDR2 | 2.02305757 |
20 | SYK | 1.84951605 |
21 | FGFR4 | 1.84497866 |
22 | TLK1 | 1.80649707 |
23 | TAOK2 | 1.80597665 |
24 | IRAK3 | 1.79966718 |
25 | PRPF4B | 1.78968254 |
26 | SIK3 | 1.77057066 |
27 | CSF1R | 1.69508697 |
28 | PIM2 | 1.54713728 |
29 | BMPR2 | 1.53473619 |
30 | KIT | 1.46251402 |
31 | MAP2K2 | 1.37720971 |
32 | BTK | 1.36988595 |
33 | MST4 | 1.29845195 |
34 | FGFR3 | 1.29192427 |
35 | BCKDK | 1.26989095 |
36 | TGFBR2 | 1.24435649 |
37 | JAK2 | 1.22050118 |
38 | ADRBK2 | 1.20048087 |
39 | MAP3K11 | 1.18095311 |
40 | IRAK1 | 1.12249290 |
41 | PKN1 | 1.09726499 |
42 | BCR | 1.09346390 |
43 | PIM1 | 1.07876927 |
44 | CSK | 1.07455570 |
45 | SIK2 | 1.06744677 |
46 | NLK | 1.00587859 |
47 | PBK | 0.99338741 |
48 | ARAF | 0.97798204 |
49 | TESK1 | 0.96345347 |
50 | NEK9 | 0.96331626 |
51 | ERN1 | 0.92069265 |
52 | HCK | 0.91133386 |
53 | LCK | 0.87681175 |
54 | LRRK2 | 0.87510973 |
55 | LYN | 0.87305191 |
56 | TAOK1 | 0.86189243 |
57 | PTK6 | 0.84986241 |
58 | PRKCQ | 0.84537256 |
59 | DYRK1B | 0.81317300 |
60 | BMX | 0.81168411 |
61 | RIPK1 | 0.80147360 |
62 | ZAP70 | 0.79167776 |
63 | RPS6KA4 | 0.70500459 |
64 | STK4 | 0.69034867 |
65 | STK10 | 0.67459519 |
66 | DAPK3 | 0.67350050 |
67 | EIF2AK2 | 0.67220129 |
68 | MARK3 | 0.66365290 |
69 | MAP3K10 | 0.65942708 |
70 | MAP3K3 | 0.63257797 |
71 | MAPKAPK2 | 0.63039721 |
72 | FGR | 0.62784741 |
73 | ACVR1B | 0.62653562 |
74 | PRKCD | 0.61433844 |
75 | GRK6 | 0.57287364 |
76 | SIK1 | 0.57181593 |
77 | CDK12 | 0.56755609 |
78 | TEC | 0.56403469 |
79 | MAPK7 | 0.56120324 |
80 | CDK4 | 0.54334958 |
81 | IRAK2 | 0.54316132 |
82 | MAPK11 | 0.53538674 |
83 | MATK | 0.53425491 |
84 | STK24 | 0.52533106 |
85 | MAPK4 | 0.51333593 |
86 | TXK | 0.51264602 |
87 | ALK | 0.50643474 |
88 | ABL1 | 0.49641454 |
89 | KDR | 0.48053441 |
90 | ZAK | 0.47369734 |
91 | MAP3K5 | 0.46863905 |
92 | EGFR | 0.43306054 |
93 | BMPR1B | 0.42482865 |
94 | RPS6KA1 | 0.42090474 |
95 | PRKAA2 | 0.40131844 |
96 | YES1 | 0.39629541 |
97 | RPS6KA5 | 0.37637627 |
98 | STK3 | 0.36943786 |
99 | TYRO3 | 0.35968983 |
100 | TNK2 | 0.33892861 |
101 | SMG1 | 0.32338745 |
102 | MAP3K8 | 0.32225507 |
103 | RPS6KC1 | 0.31363967 |
104 | RPS6KL1 | 0.31363967 |
105 | MAP2K3 | 0.29867460 |
106 | VRK1 | 0.29689392 |
107 | RPS6KA2 | 0.29576892 |
108 | MAP3K9 | 0.29548217 |
109 | CDC42BPA | 0.28279388 |
110 | PTK2B | 0.26728054 |
111 | MAP3K1 | 0.26433959 |
112 | RPS6KA6 | 0.26306624 |
113 | FES | 0.25309970 |
114 | CDK6 | 0.25052940 |
115 | FYN | 0.24995388 |
116 | ITK | 0.24297055 |
117 | MOS | 0.24167425 |
118 | PDK1 | 0.23865103 |
119 | CAMKK2 | 0.23754698 |
120 | DYRK3 | 0.22706804 |
121 | INSR | 0.22652550 |
122 | PRKCZ | 0.22590995 |
123 | GRK1 | 0.19681364 |
124 | HIPK2 | 0.17742050 |
125 | MAP2K6 | 0.17418856 |
126 | ABL2 | 0.15765692 |
127 | FLT3 | 0.15568765 |
128 | PRKCE | 0.14979110 |
129 | CLK1 | 0.14331050 |
130 | TAOK3 | 0.14293554 |
131 | SRC | 0.14110261 |
132 | ERBB3 | 0.13778898 |
133 | WNK1 | 0.11216489 |
134 | MAPK3 | 0.11021531 |
135 | AKT1 | 0.10548766 |
136 | SGK1 | 0.10243482 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 4.19150148 |
2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.42070920 |
3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.37211178 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.30232084 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.94144607 |
6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.89628533 |
7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.64887744 |
8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.55439349 |
9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.54144541 |
10 | Measles_Homo sapiens_hsa05162 | 2.48111575 |
11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.45255854 |
12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.43275471 |
13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.42673974 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.40387856 |
15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.36180748 |
16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.30582651 |
17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23333295 |
18 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.10439563 |
19 | Influenza A_Homo sapiens_hsa05164 | 2.00715372 |
20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.99896744 |
21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.95543363 |
22 | Legionellosis_Homo sapiens_hsa05134 | 1.91324816 |
23 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.86520293 |
24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.86179881 |
25 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.79285708 |
26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.75636550 |
27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.73536681 |
28 | Apoptosis_Homo sapiens_hsa04210 | 1.69621792 |
29 | Asthma_Homo sapiens_hsa05310 | 1.69408164 |
30 | Tuberculosis_Homo sapiens_hsa05152 | 1.63731194 |
31 | Pertussis_Homo sapiens_hsa05133 | 1.63225200 |
32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.60583282 |
33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.54506071 |
34 | Malaria_Homo sapiens_hsa05144 | 1.45332887 |
35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43071313 |
36 | Shigellosis_Homo sapiens_hsa05131 | 1.30562992 |
37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25329999 |
38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14887653 |
39 | Hepatitis B_Homo sapiens_hsa05161 | 1.14837015 |
40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.11891917 |
41 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.11018698 |
42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10791151 |
43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09694387 |
44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09348938 |
45 | Salmonella infection_Homo sapiens_hsa05132 | 1.06152875 |
46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05486096 |
47 | Hepatitis C_Homo sapiens_hsa05160 | 1.01799434 |
48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91279483 |
49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86733339 |
50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85864898 |
51 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85863890 |
52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76746148 |
53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76655746 |
54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76242843 |
55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74251899 |
56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71350986 |
57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70990416 |
58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70847124 |
59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67363418 |
60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63569355 |
61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60931416 |
62 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57359104 |
63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56694684 |
64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54326891 |
65 | Phagosome_Homo sapiens_hsa04145 | 0.53545353 |
66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53318258 |
67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51436701 |
68 | Bladder cancer_Homo sapiens_hsa05219 | 0.50609345 |
69 | Amoebiasis_Homo sapiens_hsa05146 | 0.50427433 |
70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49154301 |
71 | Proteasome_Homo sapiens_hsa03050 | 0.48077317 |
72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43663500 |
73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41454464 |
74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39287675 |
75 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38065316 |
76 | Lysosome_Homo sapiens_hsa04142 | 0.37217297 |
77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37058862 |
78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.36933042 |
79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34043542 |
80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32576132 |
81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32307619 |
82 | Insulin resistance_Homo sapiens_hsa04931 | 0.31852265 |
83 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.31189697 |
84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31160840 |
85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30984185 |
86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30233597 |
87 | Alcoholism_Homo sapiens_hsa05034 | 0.29500556 |
88 | Platelet activation_Homo sapiens_hsa04611 | 0.28481229 |
89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27868232 |
90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.24729434 |
91 | Prion diseases_Homo sapiens_hsa05020 | 0.24130860 |
92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23511985 |
93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23055121 |
94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.22821546 |
95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22150349 |
96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21972556 |
97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21250047 |
98 | Pathways in cancer_Homo sapiens_hsa05200 | 0.20439146 |
99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.19361814 |
100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17735657 |
101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.16080720 |
102 | Endocytosis_Homo sapiens_hsa04144 | 0.15433131 |
103 | Prostate cancer_Homo sapiens_hsa05215 | 0.14899516 |
104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14449631 |
105 | Mineral absorption_Homo sapiens_hsa04978 | 0.13347267 |
106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.11417197 |
107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.11013834 |
108 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 0.10911243 |
109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.08822018 |
110 | ABC transporters_Homo sapiens_hsa02010 | 0.08036229 |
111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.07658378 |
112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.07601984 |
113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.06900383 |
114 | Adherens junction_Homo sapiens_hsa04520 | 0.06883404 |
115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.06576177 |
116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.05189205 |
117 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.04991106 |
118 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.03113491 |
119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.01762204 |
120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.00389760 |
121 | PPAR signaling pathway_Homo sapiens_hsa03320 | -0.0231780 |
122 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | -0.0142535 |
123 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | -0.0065088 |